Patrick F. Williams - 13 Feb 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ Patrick F. Williams
Issuer symbol
BRTX
Transactions as of
13 Feb 2024
Net transactions value
$0
Form type
4
Filing time
15 Feb 2024, 16:25:23 UTC
Previous filing
11 Aug 2023
Next filing
11 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +79,646 $0.000000 79,646 13 Feb 2024 Common Stock 79,646 $1.45 Direct F3
holding BRTX Stock Option 10,490 13 Feb 2024 Common Stock 10,490 $5.08 Direct F1
holding BRTX Stock Option 32,028 13 Feb 2024 Common Stock 32,028 $2.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is currently exercisable.
F2 The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing every month thereafter until fully vested.
F3 The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested.